Opus Genetics (IRD) PT Lowered to $9 at RBC Capital
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Price: $5.22 +0.77%
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
RBC Capital analyst Lisa Walter lowered the price target on Opus Genetics (NASDAQ: IRD) to $9.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- RBC Capital Downgrades LVMH (MC:FP) (LVMUY) to Sector Perform
- Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
- Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK245 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
